Financial Performance - As of September 30, 2022, the Company reported a net income of $818,936 for the three months ended, primarily due to $1,013,450 earnings on marketable securities held in the trust account[111]. - For the nine months ended September 30, 2022, the Company had a net income of $519,213, with $1,366,301 earnings on marketable securities offsetting various expenses[112]. Initial Public Offering (IPO) - The Company completed its Initial Public Offering on January 18, 2022, raising gross proceeds of $189,750,000 from the sale of 18,975,000 units[106]. - A total of $191,647,500 from the IPO proceeds and private placement warrants was placed in a U.S.-based trust account[109]. - The underwriter of the IPO is entitled to a deferred discount of $6,641,250, payable only upon the completion of a Business Combination[119]. Financial Position - As of September 30, 2022, the Company had $280,325 in cash and a working capital deficit of $367,992[113]. - The Company has no long-term debt or capital lease obligations as of September 30, 2022[117]. Business Operations and Risks - The Company has incurred significant costs in pursuit of financing and acquisition plans, raising doubts about its ability to continue as a going concern within one year[115]. - The Company has not commenced any operations and will not generate operating revenues until after completing a Business Combination[110]. - The Company has identified risks associated with being an early-stage and emerging growth company, which may impact its future performance[104]. Internal Controls - The Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the company's disclosure controls and procedures as of September 30, 2022, concluding they were effective[128]. - There were no changes in internal control over financial reporting during the most recently completed fiscal quarter that materially affected the internal control[129].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41219 CONSILIUM ACQUISITION CORP I, LTD. (Exact name of registrant as specified in its charter) Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Cayman Islands 98-160278 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41219 CONSILIUM ACQUISITION CORP I, LTD. (Exact name of registrant as specified in its charter) Cayman Islands 98-16027 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) (Exact name of registrant as specified in its charter) Cayman Islands 98-1602789 (State or other jurisdiction of incorporation or organization) 2400 E. Commercial Boulevard, Suite 900 Ft. Lauderdale, Florida (Address of Principal Executive Offices) (Zip Code) (I.R.S. Employer Identification No.) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal ye ...